Myelomastocytic leukemia versus mast cell leukemia versus systemic mastocytosis associated with acute myeloid leukemia: A diagnostic challenge

被引:39
作者
Arredondo, Angela R.
Gotlib, Jason [2 ]
Shier, Luke [3 ]
Medeiros, Bruno [2 ]
Wong, Kathleen [3 ]
Cherry, Athena
Corless, Christopher [4 ]
Arber, Daniel A.
Valent, Peter [5 ]
George, Tracy I. [1 ]
机构
[1] Stanford Univ, Med Ctr, Sch Med, Dept Pathol, Stanford, CA 94305 USA
[2] Stanford Univ, Sch Med, Dept Med, Div Hematol, Stanford, CA 94305 USA
[3] Univ Alberta Hosp, Dept Lab Med & Pathol, Edmonton, AB T6G 2R7, Canada
[4] Oregon Hlth & Sci Univ, Dept Pathol, Portland, OR 97201 USA
[5] Med Univ Vienna, Dept Internal Med 1, Div Hematol, Vienna, Austria
关键词
KIT MUTATION; T(8/21); D816V; CLASSIFICATION; DELINEATION; DASATINIB; CRITERIA; DISEASES; PATIENT; ASP-816;
D O I
10.1002/ajh.21713
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:600 / 606
页数:7
相关论文
共 29 条
  • [1] [Anonymous], WHO CLASSIFICATION T
  • [2] Acute myeloid leukaemia with t(8;21) associated with ''occult'' mastocytosis. Report of an unusual case and review of the literature
    Bernd, HW
    Sotlar, K
    Lorenzen, J
    Osieka, R
    Fabry, U
    Valent, P
    Horny, HP
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 2004, 57 (03) : 324 - 328
  • [3] Allele-specific polymerase chain reaction for the imatinib-resistant KIT D816V and D816F mutations in mastocytosis and acute myelogenous leukemia
    Corless, Christopher L.
    Harrell, Patina
    Lacouture, Mario
    Bainbridge, Troy
    Le, Claudia
    Gatter, Ken
    White, Clifton, Jr.
    Granter, Scott
    Heinrich, Michael C.
    [J]. JOURNAL OF MOLECULAR DIAGNOSTICS, 2006, 8 (05) : 604 - 612
  • [4] Molecular genetics of acute myeloid leukaemia
    Dash, A
    Gilliland, DG
    [J]. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2001, 14 (01) : 49 - 64
  • [5] Systemic mastocytosis associated with acute myeloid leukemia:: Case report and implications for disease pathogenesis
    Escribano, L
    García-Montero, A
    Núñez-López, R
    López-Jiménez, J
    Almeida, J
    Prados, A
    Orfao, A
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2004, 114 (01) : 28 - 33
  • [6] Activity of the tyrosine kinase inhibitor PKC412 in a patient with mast cell leukemia with the D816V KIT mutation
    Gotlib, J
    Berubé, C
    Growney, JD
    Chen, CC
    George, TI
    Williams, C
    Kajiguchi, T
    Ruan, J
    Lilleberg, SL
    Durocher, JA
    Lichy, JH
    Wang, YF
    Cohen, PS
    Arber, DA
    Heinrich, MC
    Neckers, L
    Galli, SJ
    Gilliland, DG
    Coutré, SE
    [J]. BLOOD, 2005, 106 (08) : 2865 - 2870
  • [7] The KIT tyrosine kinase inhibitor midostaurine (PKC412) exhibits a high response rate in aggressive systemic mastocytosis (ASM): Interim results of a phase II trial
    Gotlib, Jason
    George, Tracy I.
    Corless, Chris
    Linder, Andrea
    Ruddell, Alisa
    Akin, Cem
    DeAngelo, Daniel J.
    Kepten, Ilana
    Lanza, Carlo
    Heinemann, Heidnan
    Yin, Ophelia
    Gallagher, Neil
    Graubert, Tim
    [J]. BLOOD, 2007, 110 (11) : 1035A - 1035A
  • [8] Mastocytosis: State of the art
    Horny, Hans-Peter
    Sotlar, Karl
    Valent, Peter
    [J]. PATHOBIOLOGY, 2007, 74 (02) : 121 - 132
  • [9] The origin of neoplastic mast cells in systemic mastocytosis with AML1/ETO-positive acute myeloid leukemia
    Nagai, Surnimasa
    Ichikawa, Motoshi
    Takahashi, Tsuyoshi
    Sato, Hiroyuki
    Yokota, Hiromitsu
    Shima, Kurni
    Izutsu, Koji
    Hangaishi, Akira
    Kanda, Yoshinobu
    Motokura, Toru
    Chiba, Shigeru
    Yatomi, Yutaka
    Kurokawa, Mineo
    [J]. EXPERIMENTAL HEMATOLOGY, 2007, 35 (11) : 1747 - 1752
  • [10] Aleukemic mast cell leukemia with abnormal immunophenotype and c-kit mutation D816V
    Noack, F
    Sotlar, K
    Notter, M
    Thiel, E
    Valent, P
    Horny, HP
    [J]. LEUKEMIA & LYMPHOMA, 2004, 45 (11) : 2295 - 2302